Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caspofungin PK and Safety in Neonates and Infants
NCT00330395Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- May 2006
- Primary completion
- Oct 2006
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
01
Overview
A Phase 2 trial of caspofungin in candidiasis, sponsored by Merck & Co.. Started May 2006; status: completed.
02
Drugs
caspofungin
03
Conditions
candidiasis
Beyond the preview
Go deeper on NCT00330395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00330395.